On September 8, 2025, the Department of Justice announced that the former chief executive officer of True Health Diagnostics, LLC, a clinical laboratory based in Frisco, Texas, agreed to pay $4.25 million to resolve allegations that he orchestrated a kickback scheme funneled through management services organizations. Two physicians and seven marketers agreed to pay an additional $1.82 million. With those settlements, the DOJ’s total civil False Claims Act recoveries for kickbacks to healthcare providers disguised as MSO investment distributions surpassed $59 million, including recoveries from 50 physicians.
The True Health case is not an isolated enforcement action. It is one piece of a years-long federal campaign targeting a specific fraud pattern: the use of management services organizations to disguise illegal payments to referring physicians as something more innocuous, such as an investment return, a consulting fee, or an administrative distribution.
What Is an MSO and Why Does It Create Fraud Risk?
A management services organization is a company that provides administrative and business support to medical practices. Billing, coding, human resources, marketing, and facilities management are all legitimate MSO functions. Physicians and medical groups contract with MSOs so that clinicians can concentrate on patient care while the management company handles operations.
In recent years, private equity firms and other investors have also used the MSO structure as a vehicle for acquiring economic control over medical practices while nominally complying with state Corporate Practice of Medicine laws. Most states prohibit non-physicians from owning or controlling medical practices on the basis that corporate ownership creates pressure to prioritize revenue over patient welfare.
The MSO model allows investors to own the management company while a physician owns the clinical entity on paper. When the MSO then crosses into controlling clinical decisions, including what tests to order or which specialists to refer patients to, the arrangement can violate both state CPOM doctrine and federal fraud law.
How MSO Arrangements Become Anti-Kickback Statute and False Claims Act Violations
The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals of services covered by Medicare, Medicaid, or other federal healthcare programs. Classic signs that an MSO is being used to facilitate kickbacks include paying investor returns with no meaningful risk or services provided, and parallel inducements such as consulting fees or copay waivers made alongside MSO distributions.
In the True Health case, marketers allegedly offered and paid physicians kickbacks disguised as MSO distributions to induce laboratory testing referrals. The former CEO allegedly facilitated the scheme’s continuation even after receiving internal warnings that the marketers “are a powder keg waiting to explode on us” and that “people are gonna go to prison.”
The kickbacks in that case did not stop with MSO distributions. The settlement also resolved allegations that the former CEO arranged for True Health to pay additional kickbacks disguised as consulting fees, processing and handling fees, and waivers of copayments and deductibles. The variety of disguises is deliberate: the payments are structured to look like legitimate business transactions at each step, making them harder to identify without inside knowledge of how the relationships actually work.
When those tainted referrals produce claims submitted to Medicare, Medicaid, or TRICARE, the False Claims Act comes into play. Every invoice that results from a referral induced by an illegal kickback is a false claim. The government can recover up to three times the amount it was improperly billed, plus penalties per false claim.
Medical Necessity and Coding Fraud Follow the Same Pattern
MSO-backed arrangements also generate medical necessity and coding fraud when non-physician management exerts pressure on clinical decisions. When administrators instruct physicians to order specific tests, up-code services, or bill for procedures not performed, and those instructions are driven by the MSO’s financial interests rather than patient care, every resulting claim submitted to federal programs carries potential FCA exposure. DOJ and qui tam relators may name a parent company, private equity sponsor, or MSO as a defendant when they direct the adoption of billing practices that generate false claims.
The DOJ Has Made MSO Enforcement a Priority
The DOJ continues to litigate a sprawling FCA qui tam lawsuit alleging kickbacks paid under the guise of MSO distributions, and the True Health settlements represent only the most recently resolved portion of a larger investigation. In fiscal year 2025, the DOJ recovered over $6.8 billion from FCA settlements and judgments, the highest annual total in the statute’s history. Healthcare fraud drove the bulk of that recovery, with kickbacks and improper billing schemes accounting for much of the government’s focus.
In July 2025, the DOJ and HHS relaunched a joint FCA Working Group explicitly targeting Medicare Advantage and kickbacks as priority areas. Enforcement guidance from the DOJ makes clear that MSO distributions, broker incentives, and administrative fee structures are all subject to Anti-Kickback Statute scrutiny. Management fee structures that cannot be justified by the services actually provided are among the arrangements regulators are most focused on.
Who Is Positioned to Report MSO Fraud?
Physicians, billing and coding staff, practice administrators, and compliance officers working within MSO-affiliated practices are typically the first to observe arrangements that cross the line into fraud. The warning signs include MSO distributions or consulting fees that physicians receive in connection with referrals, pressure from non-physician management to order specific tests or refer to particular providers, billing instructions that inflate service codes beyond what was actually performed, and contractual terms that effectively strip physicians of control over clinical decisions.
Anyone with direct knowledge of these practices can file a qui tam lawsuit under the False Claims Act on behalf of the United States. When a qui tam action is successful, the whistleblower may be eligible to receive a percentage of the government’s recovery. In the True Health case, a qui tam relator initiated the lawsuit that ultimately produced more than $59 million in government recoveries.
Speak with a Whistleblower Attorney Before Taking Any Other Steps
MSO arrangements are legally complex, and determining whether a specific fee structure or management contract crosses from aggressive to fraudulent requires careful analysis. An experienced whistleblower attorney can evaluate the facts, advise on whether the conduct you have witnessed is likely to support a viable claim, and file the qui tam complaint correctly.
Contact Keller Grover today if you have knowledge of potential MSO fraud. Our whistleblower attorneys handle False Claims Act and Anti-Kickback Statute cases and can walk you through your rights and options before you take any other steps.